Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market

Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market contains market size and forecasts of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) in global, including the following market information:
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Sales, 2017-2022, 2023-2028, (K L)
Global top five Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) companies in 2021 (%)
The global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vials Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) include Abbott, Amgen, Arven Pharmaceuticals, Biocon, Cadila Pharmaceuticals, Dr.Reddy's Laboratories, Emcure Pharmaceuticals, Intas Pharmaceuticals and Kyowa Kirin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Segment Percentages, by Type, 2021 (%)
Vials
Prefilled
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Segment Percentages, by Application, 2021 (%)
Myelosuppressive Chemotherapy
Leukemia Chemotherapy
Others
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) revenues share in global market, 2021 (%)
Key companies Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) sales in global market, 2017-2022 (Estimated), (K L)
Key companies Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Amgen
Arven Pharmaceuticals
Biocon
Cadila Pharmaceuticals
Dr.Reddy's Laboratories
Emcure Pharmaceuticals
Intas Pharmaceuticals
Kyowa Kirin
Novartis
Pfizer
Reliance Life Sciences
Harbin Pharmaceutical
North China Pharmaceutical
Jiuyuan Gene
Kexing Biopharm
Qilu Pharmaceutical
Quangang Pharmaceutical
Sunway Biotech
SL Pharmaceutical
Four Rings Bio-Pharmaceutical
Amoytop
Wuzhong Pharmaceutical